Navigation Links
AHRQ Expands Therapeutics Education and Research Centers and Adds New Topics: Health IT, Economics, Formularies
Date:10/12/2007

ROCKVILLE, Md., Oct. 12 /PRNewswire-USNewswire/ -- The Agency for Healthcare Research and Quality, part of the U.S. Department of Health and Human Services, announced today the award of $41.6 million over the next 4 years for a new coordinating center and 10 research centers as part of its Centers for Education and Research on Therapeutics program. Four new centers are also added to the CERTs program.

"Expanding the Centers for Education and Research on Therapeutics Program allows AHRQ to build a strong evidence base that consumers, clinicians, and others can use to make critical treatment decisions about therapeutic products and interventions," said AHRQ Director Carolyn M. Clancy, M.D. "The increased number and breadth of expertise in the CERTs will broaden the range of knowledge to help the health care system make measurable improvements in the quality and safety of medications and other treatments and health care."

The new AHRQ-funded CERTs Coordinating Center is Kaiser Permanente's Center for Health Research in Portland, Ore. In addition to assuming infrastructure and leadership support for the CERTs National Steering Committee and research centers, the Center for Health Research will expand the program's ability to translate research findings through collaborations with other research networks, including the National Institutes of Health Roadmap's Clinical Trials Initiative, the NIH Clinical and Translational Science Awards, and AHRQ's Effective Healthcare Program.

In addition to the new coordinating center, there are now 14 CERTs program centers in all. The four new centers receiving first-time funding are:

-- Brigham and Women's Hospital in Boston, which will focus is how health

information technology can improve the safe use of medications

-- The University of Illinois at Chicago, which will focus is how

reinvigorating formularies promote best medication uses

-- Cincinnati's Children's Hospital Medical Center, which will focus is

improving pediatric patient care through projects, such as how

children's metabolism may affect drug effectiveness and safety; and

-- The University of Chicago which will focus is hospital use of

medications and other therapeutics and their clinical and economic

implications.

Six previously funded CERTs research centers won new funding awards. They are: Duke University (therapies for disorders of the heart and blood vessels); Harvard Pilgrim Health Care on behalf of the HMO Research Network (drug use, safety, and effectiveness in defined populations cared for by health plans); University of Alabama at Birmingham (therapies for disorders of the joints and bones); The Arizona CERT at The Critical Path Institute (potentially harmful drug interactions, particularly in women); University of Pennsylvania (therapies for infectious diseases); and Vanderbilt University (prescription drug use in a Medicaid population).

The remaining four centers, which received funding in 2006, are: MD Anderson, Texas (risk and health communication; patient, consumer, and professional education); Rutgers, The State University of New Jersey (mental health therapies); the University of Iowa (improving elderly care, both therapeutics and care management); and the Weill Medical College of Cornell University, New York (therapeutic medical devices).

The CERTs program, which AHRQ administers in partnership with the FDA, was originally authorized by Congress in 1997 to examine the benefits, risks, and cost-effectiveness of therapeutic products; educate patients, consumers, doctors, pharmacists, and other clinical personnel; and improve quality of care while reducing unnecessary costs by increasing appropriate use of therapeutics and preventing adverse effects and their medical consequences. Agency for Healthcare Research and Quality

Contact: AHRQ Public Affairs

(301)427-1258

(301)427-1855


'/>"/>
SOURCE Agency for Healthcare Research and Quality
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. The Cleveland Clinic Expands Its Services across the World via the Net
2. Ranbaxy Expands By Acquiring A Generic Company In Belgium
3. Insulin and Growth Hormone, Expands Life Span?
4. Health Insurance Company Expands Product Range
5. Bird Flu Outbreak Expands in Vietnam
6. VBI Provides Potential Targets to Diabetes Therapeutics
7. CELL THERAPEUTICS PAYS Heavily to Resolve Dispute FOR ALLEGED ILLEGAL MARKETING OF CANCER DRUG
8. Paracetamol May Cause Live Damage Warns Consumer Education and Research Centre
9. Education Levels Found To Predict Stress
10. Education in women brings sounder sleep
11. Education And Income Level May Not Guarantee Health
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/17/2017)... ... February 17, 2017 , ... For ... assistance management solution to the exhibit floor for the 2017 HIMSS Conference ... , From Feb. 19–23, 2017, more than 40,000 healthcare industry professionals are expected ...
(Date:2/17/2017)... Seattle, WA (PRWEB) , ... February 17, 2017 ... ... health management organizations, has been named a finalist in the 8th Annual DecisionHealth ... impacting America's healthcare delivery system. Qualis Health’s work is recognized across multiple award ...
(Date:2/17/2017)... ... 2017 , ... Pharmica Consulting attended CHI's 8th Annual SCOPE ... trial planning and management. Pharmica discussed the importance of effective project management, data ... by Pharmica’s booth were able to demo its cloud-based Resource Management Tool, ...
(Date:2/17/2017)... ... February 17, 2017 , ... Top neuroendocrine cancer doctors, nurses and specialists from ... February 21 - 23 in Beaver Creek, CO. It was announced today by Cindy ... year in Beaver Creek, hosting over 60 faculty members and addressing unmet needs of ...
(Date:2/16/2017)... ... 17, 2017 , ... For some cancer survivors, the memories ... Physician researchers at The Marcus Institute of Integrative Health at Thomas Jefferson ... reducing symptoms of traumatic stress in cancer patients and published their results ...
Breaking Medicine News(10 mins):
(Date:2/17/2017)... 17, 2017  Noble Capital Markets announced today that ... (Nasdaq: EPIX ). The report was issued ... , PhD. ESSA Pharmaceuticals is a clinical ... cancer (CRPC). Its lead compound EPI-506, is a small ... of the androgen receptor, thereby has potential to overcome ...
(Date:2/16/2017)... Quest Diagnostics (NYSE: DGX ), ... announced that it has been named one of the ... The annual survey designated Quest Diagnostics as ... Pharmacy and Other Services" industry to attain Most Admired ... attain the designation. This is the second consecutive year ...
(Date:2/16/2017)... Feb. 16, 2017  Aralez Pharmaceuticals Inc. (NASDAQ: ... company, today announced that executive management will participate in ... held February 22-23, 2017. Adrian Adams , Chief ... at 1:35 p.m. local time on Wednesday, February 22, ... for the event may be accessed from the Investors ...
Breaking Medicine Technology: